· Manuel Jeru Manoj, KVL Narasinga Rao, GK Chetan. Implications of MGMT promoter methylation and its downstream hMSH2 mRNA in primary malignant glioma. medRixv 2019 doi :https://doi.org/10.1101/19008763.
· Manuel Jeru Manoj, Ghosh Debarati, et al. (2016). Role of concurrent methylation pattern of MGMT, TP53 and CDKN2A genes in prognosis of high-grade glioma. Journal of Carcinogenesis and Mutagenesis. 7(1).
· MK Sibin, I Bhat Dhananjaya, KVL Narasinga Rao, SM Harshitha, Manuel Jeru Manoj, GK Chetan. (2016). Two gene polymorphisms (rs4977756 and rs11515) in CDKN2A/B and glioma risk in South Indian population. Meta Gene. 9: 215-218.
· Ch Lavanya, MK Sibin, MM Srinivas Bharath, Manuel Jeru Manoj, et al. (2016). RNA interference mediated downregulation of human telomerase reverse transcriptase(hTERT) in LN18 cells. Cytotechnology. 68(6): 2311-2321.
· HN Venkatesh#, Manuel Jeru Manoj#, Ghosh Debarati, GK Chetan. (2015). Environmental Pollutants leading to carcinogenesis: process of natural selection of human cells due to chronic inflammation and sustained stress environment. International Journal of Environmental Science and Technology. 12(7): 2415-2426. #Equal contribution
· MK Sibin, Bhat Dhananjaya I, Ch Lavanya, Manuel Jeru M, et al. (2014). CDKN2A exon-wise deletion status and novel somatic mutations in Indian glioma patients. Tumor Biology. 35(2): 1467-1472.
· Jeru Manoj M, Chetan G K, Narasinga Rao K. V. L.,Venkatesh H N, Sibin M K and Lavanya Ch. The role of Direct DNA Repair gene O6-methylguanine-DNA methyltransferase (MGMT) in High Grade Malignant Glioma. Molecular Cytogenetics 2014, 7(Suppl 1): P8.
· Chetan G. K., Sibin M. K, Lavanya Ch., Jeru Manoj M., Dhananjaya I. Bhat. Exon wise deletion status of tumor suppressor P16 gene in high grade glioma in the Indian population. European journal of Human Genetics 2013, 21 (Suppl 2): P11.142. |